Healing & Repair

KLOW (10/10/50/10)

High-strength variant of the KLOW four-peptide healing blend (BPC-157 + TB-500 + GHK-Cu + KPV at double mass), permitting fewer injections per cycle.

Quick facts

Molecular weight

1,419 Da

Half-life

4 h

Frequency

daily

Admins / wk

Routes

SubQ

Typical dose

250 mcg–500 mcg

Mechanism & positioning

High-strength variant of the KLOW four-peptide healing blend (BPC-157 + TB-500 + GHK-Cu + KPV at double mass), permitting fewer injections per cycle.

Researched for: tissue repair, anti-inflammatory signalling, wound healing.

Blend composition

Component	Mass in vial	% of blend
BPC-157	10 mg	12.5%	Profile
TB-500	10 mg	12.5%	Profile
GHK-Cu	50 mg	62.5%	Profile
KPV	10 mg	12.5%	Profile

Reconstitution defaults

Default vial

80 mg

BAC water

3 mL

Concentration

26667 mcg/mL

Doses per vial

~320

Calculate with this peptide

Related peptides in the Healing & Repair class

Frequently asked questions about KLOW (10/10/50/10)

What is the typical research dose range for KLOW (10/10/50/10)?

KLOW (10/10/50/10) is most commonly investigated at 250 mcg–500 mcg per administration, daily. Note: per BPC-157 component; other components scale proportionally. These values reflect documented research-stage protocols and are not medical recommendations.

What is the half-life of KLOW (10/10/50/10)?

KLOW (10/10/50/10) has an approximate plasma half-life of 4 hours. Practical steady state is reached after roughly five half-lives — about 1 days under continuous administration.

How is KLOW (10/10/50/10) administered in research protocols?

Published research uses subq administration. Typical reconstitution is 80 mg vial in 3 mL of bacteriostatic water, producing a concentration of 26667 mcg/mL.

What vial sizes are commonly available for KLOW (10/10/50/10)?

Common stocked vial sizes are 80 mg. The 80 mg vial is the most-used default in published protocols.